Fexofenadine Export Market Intelligence: India's 224 Suppliers Shipping to 97 Countries — TransData Nexus 2026

Q: Who are the top fexofenadine exporters from India?

The top fexofenadine exporters from India are: 1. GRANULES INDIA LIMITED — $17.7M (16.1% market share); 2. IND SWIFT LIMITED — $14.6M (13.3% market share); 3. CIPLA LIMITED — $13.6M (12.4% market share); 4. DR.REDDY'S LABORATORIES LTD — $12.6M (11.5% market share); 5. SUN PHARMACEUTICAL INDUSTRIES LIMITED — $10.0M (9.1% market share). Together they account for 62.4% of India's total fexofenadine export value.

Q: What is the total export value of fexofenadine from India?

The total export value of fexofenadine from India is $109.6M USD, recorded across 4,236 shipment transactions from 224 active exporters to 97 destination countries. The average shipment value is $25.9K.

Q: Which countries import fexofenadine from India?

India exports fexofenadine to 97 countries worldwide. The top importing countries are: UNITED KINGDOM (30.8% share, $33.8M), UNITED STATES (26.9% share, $29.5M), IRELAND (10.0% share, $11.0M), AUSTRALIA (8.1% share, $8.8M), BELGIUM (4.6% share, $5.0M). These five markets account for 80.4% of total export value.

Q: What is the HS code for fexofenadine exports from India?

The primary HS code for fexofenadine exports from India is 30049039. This 8-digit classification falls under Chapter 30 (pharmaceutical products) of the Harmonized System and is used by Indian Customs (DGFT) for tracking and reporting pharmaceutical trade flows.

Q: What is the average price of fexofenadine exports from India?

The average unit price for fexofenadine exports from India is $7.89 USD per unit, with prices ranging from $0.01 to $3844.45 depending on formulation, packaging, and order volume. The total market is valued at $109.6M across 4,236 shipments.

Q: Which ports handle fexofenadine exports from India?

The primary ports for fexofenadine exports from India are SAHAR AIR (13.4% of shipments), JNPT/ NHAVA SHEVA SEA (9.1% of shipments), SAHAR AIR CARGO ACC (INBOM4) (8.5% of shipments), NHAVA SHEVA SEA (INNSA1) (8.3% of shipments), HYDERABAD ICD (5.4% of shipments). These ports have dedicated pharmaceutical cargo infrastructure ensuring cold-chain and regulatory compliance during transit.

Q: Why is India a leading exporter of fexofenadine?

India is one of the world's leading exporters of fexofenadine due to its large base of 224 WHO-GMP and US FDA approved manufacturers, significantly lower production costs compared to Western markets, well-established API (Active Pharmaceutical Ingredient) supply chains, and strong government support for pharmaceutical exports through the Pharmaceuticals Export Promotion Council (Pharmexcil). India exports fexofenadine to 97 countries, demonstrating 50% global market coverage.

Q: What certifications do Indian fexofenadine exporters need?

Indian fexofenadine exporters typically require WHO-GMP (Good Manufacturing Practice) certification for most regulated markets, US FDA approval for exports to the United States, EU GMP certification for European markets, and country-specific regulatory approvals for markets in Africa, Asia, and Latin America. Additional certifications may include ISO 9001, Schedule M compliance under Indian drug laws, and Free Sale Certificates issued by the Central Drugs Standard Control Organization (CDSCO).

Q: How many buyers import fexofenadine from India?

There are 599 registered buyers importing fexofenadine from India, spread across 97 countries. The repeat buyer rate is 58.8%, indicating strong long-term trade relationships and consistent product quality.

Q: What is the market share of the top fexofenadine supplier from India?

GRANULES INDIA LIMITED is the leading fexofenadine exporter from India with a market share of 16.1% and total export value of $17.7M across 194 shipments. The top 5 suppliers together control 62.4% of total export value.

Suresh Sormare

Fexofenadine

India Pharmaceutical Trade Intelligence

$109.6M224 Suppliers97 CountriesHS 30049039

ExportsIndia → UNITED KINGDOM30.8%India → UNITED STATES26.9%

ImportsSINGAPORE → India$150.2K BRAZIL → India$14.3K

#1 Supplier: GRANULES INDIA

Fexofenadine Export Analysis | India Pharmaceutical Trade Intelligence | TransData Nexus

How India Exports Fexofenadine to the World

Between 2022 and 2026, India exported $109.6M worth of fexofenadine across 4,236 verified shipments to 97 countries — covering 50% of world markets in the Antihistamines & Allergy segment. The largest destination is UNITED KINGDOM (30.8%). GRANULES INDIA LIMITED leads with a 16.1% share. All figures are drawn from Indian Customs (DGFT) shipping bill records spanning four years of trade activity.

Source: Indian Customs (DGFT)·Published March 2026·Updated March 2026·

Fexofenadine export data from India — top exporters, importing countries, pricing and trade statistics compiled by TransData Nexus — Fexofenadine export data snapshot — $109.6M · 224 exporters · 97 countriesTransData Nexus · Indian Customs Data

Top Fexofenadine Exporters from India

224 active exporters · Ranked by export value

View all 224 →

Top Fexofenadine Exporters from India — Ranked by Export Value
#	Supplier Name	Export Value (USD)	Shipments	Countries	Market Share
1	GRANULES INDIA LIMITED	$17.7M	194	1	16.1%
2	IND SWIFT LIMITED

Top Countries Importing Fexofenadine from India

97 destination markets · Ranked by import value

All 97 countries →

Top Countries Importing Fexofenadine from India — Ranked by Import Value
#	Country	Import Value (USD)	Market Share
1	UNITED KINGDOM	$33.8M	30.8%
2	UNITED STATES	$29.5M	26.9%
3	IRELAND	$11.0M	10.0%
4	AUSTRALIA	$8.8M	8.1%
5	BELGIUM	$5.0M	4.6%
6	BRAZIL	$5.0M	4.5%
7	RUSSIA	$3.4M	3.1%
8	SRI LANKA	$1.8M	1.6%
9	NETHERLANDS	$1.3M	1.2%
10	CHILE	$1.1M	1.0%

UNITED KINGDOM is India's largest fexofenadine export destination, absorbing 30.8% of total exports worth $33.8M. The top 5 importing countries — UNITED KINGDOM, UNITED STATES, IRELAND, AUSTRALIA, BELGIUM — together account for 80.4% of India's total fexofenadine export value. The remaining 92 destination countries collectively receive the other 19.6%, indicating a broadly diversified export footprint across multiple regions.

Who Supplies Fexofenadine to India?

8 origin countries · Total import value: $182.1K

India imports fexofenadine from 8 countries with a combined import value of $182.1K. The largest supplier is SINGAPORE ($150.2K, 1 shipments), followed by BRAZIL and UNITED STATES. All values are from Indian Customs (DGFT) import records.

Countries Supplying Fexofenadine to India — Ranked by Import Value
#	Origin Country	Import Value (USD)	Shipments	Share
1	SINGAPORE	$150.2K	1	82.5%
2	BRAZIL	$14.3K	13	7.8%
3	UNITED STATES	$12.5K	32	6.9%
4	GERMANY	$2.4K	3	1.3%
5	UNITED KINGDOM	$1.4K	4	0.8%
6	AUSTRALIA	$1.3K	4	0.7%
7	TURKEY	$19	2	0.0%
8	SAUDI ARABIA	$12	2	0.0%

SINGAPORE is the largest supplier of fexofenadine to India, accounting for 82.5% of total import value. The top 5 origin countries — SINGAPORE, BRAZIL, UNITED STATES, GERMANY, UNITED KINGDOM — together supply 99.3% of India's fexofenadine imports. Click any country to see detailed supplier and buyer data for that import corridor.

Fexofenadine — Export Intelligence Video

Visual overview of India's fexofenadine import and export market — top suppliers, destinations, pricing, and trade routes

This video covers India's fexofenadine pharmaceutical import and export market — $109.6M in total trade, 224 verified manufacturers, and 97 destination countries. Data sourced from Indian Customs (DGFT) shipment records.

Regulatory Landscape — Fexofenadine

Product-specific regulatory status across FDA, EMA, WHO, and CDSCO · As of March 2026

1FDA & US Market Regulatory Status

In the United States, fexofenadine is approved for use in various formulations, including oral tablets and suspensions. The FDA's Orange Book lists multiple approved Abbreviated New Drug Applications (ANDAs) for fexofenadine hydrochloride, indicating a competitive generic market. Notably, Impax Laboratories received approval for their ANDA 076298 for Fexofenadine Hydrochloride and Pseudoephedrine Hydrochloride Extended-release Tablets (60 mg/120 mg) on September 3, 2010.

The substantial number of approved ANDAs reflects the active participation of numerous Indian exporters in the U.S. market. However, it is crucial for exporters to remain vigilant regarding FDA import alerts and compliance requirements to ensure uninterrupted market access.

2EU & UK Regulatory Framework

In the European Union, fexofenadine is subject to marketing authorization by national competent authorities. The European Medicines Agency (EMA) conducted a Periodic Safety Update Report Single Assessment (PSUSA) for fexofenadine, resulting in a variation to the terms of the marketing authorization in January 2023. (ema.europa.eu) This underscores the importance of ongoing pharmacovigilance and compliance with EU Good Manufacturing Practice (GMP) requirements.

In the United Kingdom, the Medicines and Healthcare products Regulatory Agency (MHRA) issued a Class 4 Medicines Defect Notification in August 2025 concerning an error with the European Article Number (EAN) barcode on certain batches of fexofenadine hydrochloride 120 mg film-coated tablets. (gov.uk) This highlights the necessity for exporters to maintain stringent quality control measures to meet UK regulatory standards.

3WHO Essential Medicines & Global Standards

Fexofenadine is included in the World Health Organization's Model List of Essential Medicines, reflecting its recognized importance in global health. Compliance with international pharmacopoeia standards, such as the United States Pharmacopeia (USP), British Pharmacopoeia (BP), European Pharmacopoeia (EP), and Indian Pharmacopoeia (IP), is essential for market acceptance and regulatory compliance.

4India Regulatory Classification

In India, fexofenadine is classified under Schedule H, indicating that it is a prescription-only medication. The Drug Price Control Order (DPCO) and the National Pharmaceutical Pricing Authority (NPPA) regulate its pricing to ensure affordability. Exporters must obtain a No Objection Certificate (NOC) from the Directorate General of Foreign Trade (DGFT) for the export of pharmaceutical products, ensuring compliance with national regulations.

5Patent & Exclusivity Status

The primary patents for fexofenadine have expired, leading to a competitive generic market. This has facilitated the entry of multiple manufacturers, including Indian exporters, into global markets.

6Recent Industry Developments

In January 2023, the EMA's PSUSA for fexofenadine resulted in a variation to the marketing authorization terms, emphasizing the need for continuous monitoring of safety data. (ema.europa.eu)

In August 2025, the MHRA issued a Class 4 Medicines Defect Notification due to a barcode error on certain batches of fexofenadine hydrochloride 120 mg tablets, highlighting the importance of accurate labeling and quality control. (gov.uk)

These developments underscore the dynamic nature of the regulatory landscape for fexofenadine and the necessity for exporters to stay informed and compliant with evolving standards.

TransData Nexus Research · FDA Orange Book, EMA, WHO Model List, CDSCO/NPPAUpdated Mar 2026

Get Complete Export Intelligence Report

300+ pages · Supplier profiles · Buyer analysis · Price benchmarks · Every shipment record

Free

Global Price Benchmark — Fexofenadine

Retail & reference prices across 9 markets vs. India FOB export price of $7.89/unit

Global Price Benchmark for Fexofenadine across major pharmaceutical markets
Market	Price (USD/unit)	Currency	Reference
United States	$0.12	USD	Fexofenadine is available over-the-counter in the United States. According to the FDA, it was approved for OTC sales in January 2011.
United Kingdom	$1.07	GBP	The UK's Medicines and Healthcare products Regulatory Agency (MHRA) reclassified fexofenadine to allow general sales in December 2020.
Germany	$0.88	EUR	Fexofenadine is regulated by the European Medicines Agency (EMA).
Australia	$0.98

Supply Chain Risk Assessment — Fexofenadine

API sourcing, concentration risk, storage requirements, and current alerts

HIGH RISK

1API Sourcing & Raw Material Dependency

India's pharmaceutical industry, including the production of Fexofenadine, heavily relies on Active Pharmaceutical Ingredients (APIs) and Key Starting Materials (KSMs) imported from China. Approximately 60–70% of these critical components are sourced from China, highlighting a significant dependency. This reliance poses a risk, as any disruption in the supply chain from China can directly impact the availability and production of Fexofenadine in India.

Recent geopolitical tensions have exacerbated this vulnerability. In February 2026, military escalations in the Middle East led to the closure of the Strait of Hormuz, a critical maritime route for global trade. This disruption has caused significant delays and increased costs in shipping, affecting the timely import of APIs and KSMs into India. Consequently, the production schedules for Fexofenadine have been adversely affected, leading to potential shortages in export markets.

2Supplier Concentration & Single-Source Risk

The export market for Fexofenadine from India is notably concentrated. The top five exporters—Granules India Limited, Ind Swift Limited, Cipla Limited, Dr. Reddy's Laboratories Ltd, and Sun Pharmaceutical Industries Limited—collectively account for 62.4% of the total export value. Granules India Limited alone holds a 16.1% share, amounting to $17.7 million USD. This high level of supplier concentration introduces a single-source risk; any operational or financial issues within these key companies could disrupt the global supply of Fexofenadine.

Access Complete Fexofenadine Trade Intelligence

Shipment-level records, verified supplier contacts, buyer histories, and pricing analytics for all 4,236 transactions across 97 markets.

Request Demo View Pricing

Frequently Asked Questions — Fexofenadine Exports from India

Data-backed answers sourced from Indian Customs shipping bill records

Who are the top fexofenadine exporters from India?

The leading fexofenadine exporters from India are GRANULES INDIA LIMITED, IND SWIFT LIMITED, CIPLA LIMITED, and 12 others. GRANULES INDIA LIMITED leads with 16.1% market share ($17.7M). The top 5 suppliers together control 62.4% of total export value.

What is the total export value of fexofenadine from India?

The total export value of fexofenadine from India is $109.6M, recorded across 4,236 shipments from 224 active exporters to 97 countries. The average shipment value is $25.9K.

Which countries import fexofenadine from India?

India exports fexofenadine to 97 countries. The top importing countries are UNITED KINGDOM (30.8%), UNITED STATES (26.9%), IRELAND (10.0%), AUSTRALIA (8.1%), BELGIUM (4.6%), which together account for 80.4% of total export value.

What is the HS code for fexofenadine exports from India?

The primary HS code for fexofenadine exports from India is 30049039. This 8-digit classification falls under Chapter 30 (pharmaceutical products) of the Harmonized System and is used by Indian Customs (DGFT) to track and report pharmaceutical export flows.

Official References & Regulatory Resources

Research Methodology & Data Transparency

Suresh Sormare

Verified Author

Pharmaceutical Export-Import Analyst & Trade Intelligence Expert

Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.

linkedin.com/in/sureshsormare

Primary Data Source

All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.

Fexofenadine

Fexofenadine

Top Fexofenadine Exporters from India

Top Countries Importing Fexofenadine from India

Who Supplies Fexofenadine to India?

Quick Facts

Related Antihistamines & Allergy

Related Analysis

Need Details?

Fexofenadine — Export Intelligence Video

Regulatory Landscape — Fexofenadine

1FDA & US Market Regulatory Status

2EU & UK Regulatory Framework

3WHO Essential Medicines & Global Standards

4India Regulatory Classification

5Patent & Exclusivity Status

6Recent Industry Developments

Global Price Benchmark — Fexofenadine

Supply Chain Risk Assessment — Fexofenadine

1API Sourcing & Raw Material Dependency

2Supplier Concentration & Single-Source Risk

Access Complete Fexofenadine Trade Intelligence

Frequently Asked Questions — Fexofenadine Exports from India

Who are the top fexofenadine exporters from India?

What is the total export value of fexofenadine from India?

Which countries import fexofenadine from India?

What is the HS code for fexofenadine exports from India?

Official References & Regulatory Resources

Research Methodology & Data Transparency

Suresh Sormare

Primary Data Source

India Cost Advantage

3Geopolitical & Shipping Disruptions

4Risk Mitigation Recommendations

What is the average price of fexofenadine exports from India?

Which ports handle fexofenadine exports from India?

Why is India a leading exporter of fexofenadine?

What certifications do Indian fexofenadine exporters need?

How many buyers import fexofenadine from India?

What is the market share of the top fexofenadine exporter from India?

Analysis Methodology